Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use ; volume:10 ; number:1 ; day:28 ; month:5 ; year:2012 ; pages:1-8 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (28.5.2012), 1-8, 12.2012
- Urheber
-
Ascierto, Paolo A.
- Beteiligte Personen und Organisationen
-
Simeone, Ester
Giannarelli, Diana
Grimaldi, Antonio M.
Romano, Anna
Mozzillo, Nicola
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-107
- URN
-
urn:nbn:de:1111-2016041441808
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ascierto, Paolo A.
- Simeone, Ester
- Giannarelli, Diana
- Grimaldi, Antonio M.
- Romano, Anna
- Mozzillo, Nicola
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
The role of BRAF V600 mutation in melanoma
MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
The role of BRAF V600 mutation in melanoma
MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
The role of BRAF V600 mutation in melanoma
MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients